CASI Pharmaceuticals Inc (CASI)
3.30
+0.06
(+1.69%)
USD |
NASDAQ |
May 17, 16:00
3.30
0.00 (0.00%)
After-Hours: 20:00
CASI Pharmaceuticals Research and Development Expense (Quarterly): 2.314M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.314M |
September 30, 2023 | 2.399M |
June 30, 2023 | 2.614M |
March 31, 2023 | 2.534M |
December 31, 2022 | 4.248M |
September 30, 2022 | 3.905M |
June 30, 2022 | 3.851M |
March 31, 2022 | 3.992M |
December 31, 2021 | 4.014M |
September 30, 2021 | 2.895M |
June 30, 2021 | 2.255M |
March 31, 2021 | 5.258M |
December 31, 2020 | 3.788M |
September 30, 2020 | 2.803M |
June 30, 2020 | 1.862M |
March 31, 2020 | 3.017M |
December 31, 2019 | 1.965M |
September 30, 2019 | 1.829M |
June 30, 2019 | 2.979M |
March 31, 2019 | 2.567M |
December 31, 2018 | 3.274M |
September 30, 2018 | 1.806M |
June 30, 2018 | 1.730M |
March 31, 2018 | 1.697M |
December 31, 2017 | 3.848M |
Date | Value |
---|---|
September 30, 2017 | 0.971M |
June 30, 2017 | 1.727M |
March 31, 2017 | 1.049M |
December 31, 2016 | 1.250M |
September 30, 2016 | 1.014M |
June 30, 2016 | 1.363M |
March 31, 2016 | 1.019M |
December 31, 2015 | 1.045M |
September 30, 2015 | 0.9423M |
June 30, 2015 | 1.223M |
March 31, 2015 | 0.865M |
December 31, 2014 | 0.784M |
September 30, 2014 | 0.697M |
June 30, 2014 | 0.7245M |
March 31, 2014 | 0.56M |
December 31, 2013 | 0.5977M |
September 30, 2013 | 0.78M |
June 30, 2013 | 0.8366M |
March 31, 2013 | 0.5064M |
December 31, 2012 | 0.4947M |
September 30, 2012 | 0.6231M |
June 30, 2012 | 0.6963M |
March 31, 2012 | 0.5612M |
December 31, 2011 | 0.4059M |
September 30, 2011 | 0.7035M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.829M
Minimum
Sep 2019
5.258M
Maximum
Mar 2021
3.080M
Average
2.895M
Median
Sep 2021